Literature DB >> 28284723

Prevalence of Surgical Repair for Athletic Pubalgia and Impact on Performance in Football Athletes Participating in the National Football League Combine.

Derrick M Knapik1, Jeremy J Gebhart2, Shane J Nho3, Joseph E Tanenbaum4, James E Voos2, Michael J Salata2.   

Abstract

PURPOSE: To examine the prevalence and impact of athletic pubalgia (AP) surgery in elite American football athletes participating in the National Football League (NFL) Combine.
METHODS: Results from 1,311 athletes participating in the Combine from 2012 to 2015 were evaluated. Athletes with a history of AP repair were identified using the NFL Combine Database. Athlete history and available imaging was reviewed. NFL performance based on draft status, games played, games started, and current status in the NFL was gathered using publicly available databases. Statistical analysis was performed to detect for significant associations between athlete history and NFL performance in the presence of AP repair and pelvic pathology on postsurgical magnetic resonance imaging (MRI).
RESULTS: AP repair was identified in 4.2% (n = 55) of athletes. MRI was performed in 35% (n = 19 of 55) with AP repair, of which 53% (n = 10 of 19) had positive pathology. Athletes with repair were not at risk of playing (P = .87) or starting (P = .45) fewer regular season games, going undrafted (P = .27), or not being on an active NFL roster (P = .51). Compared with athletes with negative imaging findings, positive pathology on MRI did not have a significant impact on games played (P = .74), games started (P = .48), draft status (P = .26), or being on an active roster (P = .74). Offensive linemen (P = .005) and athletes with a history of repair within 1 year of the Combine (P = .03) had a significantly higher risk of possessing positive pathology on MRI.
CONCLUSIONS: Athletes with a history of successful AP surgery invited to the NFL Combine and those with persistent pathology on MRI are not at increased risk for diminished performance in the NFL. Offensive linemen and athletes less than 1 year out from surgery have a higher risk for positive MRI findings at the pubic symphysis. LEVEL OF EVIDENCE: Level IV, prognostic study-case series.
Copyright © 2017 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28284723     DOI: 10.1016/j.arthro.2017.01.024

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  6 in total

Review 1.  Hip and Groin Injuries in Baseball Players.

Authors:  Ryan A Mlynarek; Struan H Coleman
Journal:  Curr Rev Musculoskelet Med       Date:  2018-03

2.  Athletes With Musculoskeletal Injuries Identified at the NFL Scouting Combine and Prediction of Outcomes in the NFL: A Systematic Review.

Authors:  Dean Wang; Leigh J Weiss; Madeline Abrams; Ronnie P Barnes; Russell F Warren; Scott A Rodeo; Samuel A Taylor
Journal:  Orthop J Sports Med       Date:  2018-12-12

Review 3.  A Systematic Review of the Orthopaedic Literature Involving National Football League Players.

Authors:  Melissa A Kluczynski; William H Kelly; William M Lashomb; Leslie J Bisson
Journal:  Orthop J Sports Med       Date:  2019-08-20

4.  Outcomes following surgical management of inguinal-related groin pain in athletes: a case series.

Authors:  Michael Gerhardt; Josh Christiansen; Benjamin Sherman; Alejandro Miranda; William Hutchinson; Jorge Chahla
Journal:  J Hip Preserv Surg       Date:  2020-01-22

Review 5.  Surgical Outcomes of Inguinal-, Pubic-, and Adductor-Related Chronic Pain in Athletes: A Systematic Review Based on Surgical Technique.

Authors:  Munif Hatem; RobRoy L Martin; Srino Bharam
Journal:  Orthop J Sports Med       Date:  2021-09-13

6.  High Return to Play Rate and Reduced Career Longevity Following Surgical Management of Athletic Pubalgia in National Basketball Association Players.

Authors:  Joshua P Castle; Adam Kessler; Muhammad J Abbas; Susan Wager; Lafi S Khalil; Kelechi R Okoroha; Nima Mehran
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-08-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.